Summary

Global Microsurgery & Super-Microsurgery Market by Equipment (Operating Microscopes, Super Micro Sutures, Micro Forceps, Microsurgery Needle Holder, Surgical Scalpel/ Ophthalmic Knives, Others), by Procedure (Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery, Others), by End User (Hospitals, Ambulatory Surgical Centers, Others), by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2032

Market Overview
Global microsurgery and super-microsurgery market was estimated to be worth USD 1,961.54 million in 2022 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.07% from 2023 to 2032, reaching USD 3,783.66 million in 2032.
Global microsurgery and super-microsurgery market is driven by the increasing volume of surgical procedures and the rising geriatric population. Advancements in R&D, growing transplant surgeries, and the need for precision in orthopedic and reconstructive procedures contribute significantly. Aging-related conditions and chronic diseases further boost demand for microsurgical interventions with high success rates across medical disciplines.
Global microsurgery and super-microsurgery market faces restraints due to risks like infection, poor healing, nerve damage, scarring, anesthesia complications, and potential need for revision surgeries.
Global microsurgery and super-microsurgery market is poised for growth due to the rising prevalence of lifestyle disorders and ongoing technological advancements. Increasing product approvals, government support, and innovation, such as developments in ophthalmic surgical microscopes, are enhancing procedural precision. As chronic diseases rise among both aging and younger populations, the demand for advanced microsurgical solutions is expected to surge.

Market Segmentations
Global microsurgery and super-microsurgery market is categorized based on equipment type and surgical procedures. The equipment segment comprises operating microscopes, super micro sutures, micro forceps, microsurgery needle holders, surgical scalpels or ophthalmic knives, and other related tools.
Orthopedic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Ophthalmic Microsurgery, Gynecological & Urological Microsurgery are the part of procedure types of global market.
In terms of end user, global microsurgery and super microsurgery market is categorized into hospitals and ambulatory surgical centers and others.
Based on the regional category, global microsurgery and super microsurgery market has been segmented into North America, Europe, Asia Pacific, and rest of the world.

Regional Insights
Global microsurgery and super-microsurgery market has seen notable regional developments, each shaped by unique drivers and challenges. In North America, market growth has been robust, driven by continuous technological advancements and an increasing preference for minimally invasive procedures across several specialties.
In Europe, the market has evolved significantly, fueled by innovations in medical technology, a growing elderly population, and the rising prevalence of chronic conditions. Both microsurgeries, using fine instruments and microscopes, and the more advanced super-microsurgery have become integral in fields such as plastic surgery, ophthalmology, orthopedics, and reconstructive surgery.
The Asia Pacific region is witnessing rapid progress due to its strong focus on research and development. Leading academic and medical institutions are pioneering new techniques, enhancing the precision and scope of these delicate surgical procedures.
Meanwhile, in the Middle East, Africa, and Latin America, the market is expanding but faces notable challenges. Although there is growing interest, limited access to specialized training, high equipment costs, and uneven healthcare infrastructure restrict the broader adoption of microsurgery and super-microsurgery across these regions.

Major Players
Johnson & Johnson Services Inc, Carl Zeiss Meditec, KLS Martin Group, Topcon Corporation, Olympus Corporation, Kontron AG, B. Braun SE, Zimmer Biomet, Global Surgical Corporation, Karl Kaps GmbH & Co. KG, Smith+Nephew, Stille AB, Medtronic, Stryker, BVI, Microsurgery Instruments Inc, Haag-Streit Group, Peter Lazic GmbH, Alco Inc, Synovis Micro Companies Alliance Inc. are the key companies of global microsurgery and super microsurgery market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ................. 22
2 MARKET INTRODUCTION .............. 24
2.1 DEFINITION .................................................................... 24
2.2 SCOPE OF THE STUDY ................................................ 24
2.3 RESEARCH OBJECTIVE .............................................. 24
2.4 MARKET STRUCTURE ................................................ 24
3 RESEARCH METHODOLOGY ........ 25
3.1 OVERVIEW ...................................................................... 25
3.2 DATA FLOW .................................................................... 27
3.2.1 DATA MINING PROCESS ......................................... 27
3.3 PURCHASED DATABASE: ........................................... 28
3.4 SECONDARY SOURCES: .............................................. 29
3.4.1 SECONDARY RESEARCH DATA FLOW: .......................... 30
3.5 PRIMARY RESEARCH: ................................................. 31
3.5.1 PRIMARY RESEARCH DATA FLOW: ......................... 32
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ........................................................................................ 33
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ............... 33
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 34
3.6.1 REVENUE ANALYSIS APPROACH .............................. 34
3.7 DATA FORECASTING................................................... 34
3.7.1 DATA FORECASTING TECHNIQUE .............................. 35
3.8 DATA END USERLING ................................................. 36
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ......................... 36
3.8.2 DATA END USERLING: ............................................ 37
3.9 TEAMS AND ANALYST CONTRIBUTION ............. 38
4 MARKET DYNAMICS ...................... 40
4.1 INTRODUCTION ............................................................. 40
4.2 DRIVERS ........................................................................... 41
4.2.1 GROWING NUMBER OF SURGICAL PROCEDURES ............. 41
4.2.2 INCREASING NUMBER OF GERIATRIC POPULATION .......... 41
4.3 RESTRAINTS .................................................................. 42
4.3.1 COMPLICATIONS AND RISKS DUE TO THE PROCEDURE .... 42
4.4 OPPORTUNITY ............................................................... 43
4.4.1 INCREASING INCIDENCE OF LIFESTYLE DISORDERS AND GROWING TECHNOLOGICAL ADVANCEMENTS ........................................ 43
5 MARKET FACTOR ANALYSIS ........ 45
5.1 VALUE CHAIN ANALYSIS ......................................... 45
5.1.1 R&D ................................................................. 46
5.1.2 MANUFACTURING .................................................. 46
5.1.3 DISTRIBUTION AND SALES ...................................... 47
5.1.4 POST-SALES MONITORING ....................................... 47
5.2 PORTER’S FIVE FORCES MODEL ............................. 48
5.2.1 THREAT OF NEW ENTRANTS ..................................... 49
5.2.2 BARGAINING POWER OF SUPPLIERS ........................... 49
5.2.3 THREAT OF SUBSTITUTES ........................................ 49
5.2.4 BARGAINING POWER OF BUYERS .............................. 49
5.2.5 INTENSITY OF RIVALRY ............................................ 49
5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET ... 50
5.3.1 IMPACT ON SUPPLY CHAIN ..................................... 50
5.3.2 IMPACT ON KEY PLAYERS ................................ 50
5.3.3 IMPACT ON DEMAND AND SUPPLY ................... 51
6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT .............. 52
6.1 OVERVIEW ...................................................................... 52
6.2 OPERATING MICROSCOPES ...................................... 55
6.3 SUPER MICRO SUTURES ............................................ 55
6.4 MICRO FORCEPS ........................................................... 56
6.5 MICROSURGERY NEEDLE HOLDER ........................ 56
6.6 SURGICAL SCALPEL/ OPHTHALMIC KNIVES ..... 57
6.7 OTHERS ............................................................................ 57
7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE ............ 58
7.1 OVERVIEW ...................................................................... 58
7.2 ORTHOPEDIC MICROSURGERY ................................ 61
7.3 OPHTHALMIC MICROSURGERY .............................. 62
7.4 PLASTIC & RECONSTRUCTIVE MICROSURGERY ............................................................................................ 62
7.5 ENT MICROSURGERY .................................................. 63
7.6 NEUROLOGICAL MICROSURGERY .......................... 63
7.7 GYNECOLOGICAL & UROLOGICAL MICROSURGERY ....................................................................................... 64
7.8 OTHERS ............................................................................ 64
8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER ................. 65
8.1 OVERVIEW ...................................................................... 65
8.2 HOSPITALS ..................................................................... 67
8.3 AMBULATORY SURGICAL CENTERS ..................... 68
8.4 OTHERS ............................................................................ 68
9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION ...................... 69
9.1 OVERVIEW ...................................................................... 69
9.2 NORTH AMERICA ......................................................... 71
9.2.1 US.................................................................... 75
9.2.2 CANADA .......................................................... 76
9.3 EUROPE ............................................................................ 78
9.3.1 GERMANY .......................................................... 82
9.3.2 FRANCE ............................................................. 83
9.3.3 UK ................................................................... 85
9.3.4 ITALY ................................................................. 86
9.3.5 SPAIN ............................................................... 88
9.3.6 REST OF EUROPE .................................................. 89
9.4 ASIA-PACIFIC ................................................................. 91
9.4.1 CHINA .............................................................. 95
9.4.2 JAPAN ............................................................. 96
9.4.3 INDIA ............................................................... 98
9.4.4 AUSTRALIA ...................................................... 99
9.4.5 SOUTH KOREA .................................................. 101
9.4.6 REST OF ASIA-PACIFIC ..................................... 102
9.5 REST OF WORLD ........................................................... 104
9.5.1 MIDDLE EAST ................................................... 108
9.5.2 SOUTH AMERICA .............................................. 109
10 COMPETITIVE LANDSCAPE .......... 111
10.1 INTRODUCTION ............................................................. 111
10.2 MARKET SHARE ANALYSIS, 2022 ......................... 111
10.3 COMPETITOR DASHBOARD....................................... 112
10.4 PUBLIC PLAYERS STOCK SUMMARY ................... 114
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL .............................................................................. 114
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................... 115
10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL ......... 115
1 0.6.2 ACQUISITION/INVESTMENT/EXPANSION .......... 115
10.7 COMPETITOR PRODUCT ANALYSIS ...................... 116
10.7.1 OPERATING MICROSCOPES .............................. 116
10.7.2 MICRO FORCEPS .............................................. 117
10.7.3 SUPER MICRO SUTURES ................................... 118
10.7.4 MICROSURGERY NEEDLE HOLDER ..................... 119
10.7.5 SURGICAL SCALPEL/ OPHTHALMIC KNIVES ...... 120
11 COMPANY PROFILES .................... 121
11.1 KONTRON AG ................................................................. 121
11.1.1 COMPANY OVERVIEW ....................................... 121
11.1.2 FINANCIAL OVERVIEW ...................................... 122
11.1.3 PRODUCTS OFFERED ........................................ 123
11.1.4 KEY DEVELOPMENTS ........................................ 124
11.1.5 KEY STRATEGIES .............................................. 124
11.2 CARL ZEISS MEDITEC AG .......................................... 125
11.2.1 COMPANY OVERVIEW ....................................... 125
11.2.2 FINANCIAL OVERVIEW ...................................... 126
11.2.3 PRODUCTS OFFERED ........................................ 126
11.2.4 KEY DEVELOPMENTS ........................................ 129
11.2.5 SWOT ANALYSIS .............................................. 130
11.2.6 KEY STRATEGIES .............................................. 130
11.3 GLOBAL SURGICAL CORPORATION ........................ 131
11.3.1 COMPANY OVERVIEW ....................................... 131
11.3.2 FINANCIAL OVERVIEW ...................................... 131
11.3.3 PRODUCTS OFFERED ........................................ 132
11.3.4 KEY DEVELOPMENTS ........................................ 132
11.3.5 KEY STRATEGIES .............................................. 132
11.4 KARL KAPS GMBH & CO. KG ..................................... 133
11.4.1 COMPANY OVERVIEW ....................................... 133
11.4.2 FINANCIAL OVERVIEW ...................................... 133
11.4.3 PRODUCTS OFFERED ........................................ 134
11.4.4 KEY DEVELOPMENTS ........................................ 134
11.4.5 KEY STRATEGIES .............................................. 134
11.5 MEDTRONIC ................................................................... 135
11.5.1 COMPANY OVERVIEW ....................................... 135
11.5.2 FINANCIAL OVERVIEW ...................................... 136
11.5.3 PRODUCTS OFFERED ........................................ 137
11.5.4 KEY DEVELOPMENTS ........................................ 137
11.5.5 SWOT ANALYSIS .............................................. 138
11.5.6 KEY STRATEGIES .............................................. 138
11.6 OLYMPUS CORPORATION ......................................... 139
11.6.1 COMPANY OVERVIEW ....................................... 139
11.6.2 FINANCIAL OVERVIEW ...................................... 140
11.6.3 PRODUCTS OFFERED ........................................ 140
11.6.4 KEY DEVELOPMENTS ........................................ 141
11.6.5 KEY STRATEGIES .............................................. 141
11.7 SMITH+NEPHEW .......................................................... 142
11.7.1 COMPANY OVERVIEW ....................................... 142
11.7.2 FINANCIAL OVERVIEW ...................................... 143
11.7.3 PRODUCTS OFFERED ........................................ 144
11.7.4 KEY DEVELOPMENTS ........................................ 144
11.7.5 KEY STRATEGIES .............................................. 144
11.8 ZIMMER BIOMET .......................................................... 145
11.8.1 COMPANY OVERVIEW ....................................... 145
11.8.2 FINANCIAL OVERVIEW ...................................... 146
11.8.3 PRODUCTS OFFERED ........................................ 146
11.8.4 KEY DEVELOPMENTS ........................................ 149
11.8.5 SWOT ANALYSIS .............................................. 149
11.8.6 KEY STRATEGIES .............................................. 149
11.9 TOPCON CORPORATION ............................................. 150
11.9.1 COMPANY OVERVIEW ....................................... 150
11.9.2 FINANCIAL OVERVIEW ...................................... 151
11.9.3 PRODUCTS OFFERED ........................................ 152
11.9.4 KEY DEVELOPMENTS ........................................ 152
11.9.5 KEY STRATEGIES .............................................. 153
11.10 STILLE AB ....................................................................... 154
11.10.1 COMPANY OVERVIEW ....................................... 154
11.10.2 FINANCIAL OVERVIEW ...................................... 155
11.10.3 PRODUCTS OFFERED ........................................ 155
11.10.4 KEY DEVELOPMENTS ........................................ 156
1 1.10.5 KEY STRATEGIES .............................................. 156
11.11 B. BRAUN SE ................................................................... 157
11.11.1 COMPANY OVERVIEW ....................................... 157
11.11.2 FINANCIAL OVERVIEW ...................................... 158
11.11.3 PRODUCT OFFERED .......................................... 159
11.11.4 KEY DEVELOPMENTS ........................................ 159
11.11.5 SWOT ANALYSIS .............................................. 160
11.11.6 KEY STRATEGY ..................................................... 160
11.12 STRYKER ......................................................................... 161
11.12.1 COMPANY OVERVIEW ....................................... 161
11.12.2 FINANCIAL OVERVIEW ...................................... 162
11.12.3 PRODUCTS OFFERED ............................................ 163
11.12.4 KEY DEVELOPMENTS ........................................ 163
11.12.5 KEY STRATEGIES .............................................. 163
11.13 BVI ..................................................................................... 164
11.13.1 COMPANY OVERVIEW ....................................... 164
11.13.2 FINANCIAL OVERVIEW ...................................... 164
11.13.3 PRODUCTS OFFERED ............................................ 165
11.13.4 KEY DEVELOPMENTS ........................................ 165
11.13.5 KEY STRATEGY ................................................. 165
11.14 JOHNSON & JOHNSON SERVICES INC .................. 166
11.14.1 COMPANY OVERVIEW ....................................... 166
11.14.2 FINANCIAL OVERVIEW ...................................... 167
11.14.3 PRODUCTS OFFERED ........................................ 167
11.14.4 KEY DEVELOPMENTS ........................................ 168
11.14.5 SWOT ANALYSIS .............................................. 168
11.14.6 KEY STRATEGIES .............................................. 168
11.15 HAAG-STREIT GROUP ................................................. 169
11.15.1 COMPANY OVERVIEW ....................................... 169
11.15.2 FINANCIAL OVERVIEW ...................................... 170
11.15.3 PRODUCTSOFFERED ......................................... 170
11.15.4 KEY DEVELOPMENTS ........................................ 170
11.15.5 KEY STRATEGIES .............................................. 170
11.16 KLS MARTIN GROUP ................................................... 171
11.16.1 COMPANY OVERVIEW ....................................... 171
11.16.2 FINANCIAL OVERVIEW ...................................... 172
11.16.3 PRODUCT OFFERED .......................................... 172
11.16.4 KEY DEVELOPMENTS ........................................ 172
11.16.5 KEY STRATEGIES .............................................. 172
11.17 MICROSURGERY INSTRUMENTS, INC .................. 173
11.17.1 COMPANY OVERVIEW ....................................... 173
11.17.2 FINANCIAL OVERVIEW ...................................... 173
11.17.3 PRODUCTS OFFERED......................................... 173
11.17.4 KEY DEVELOPMENTS ........................................ 174
11.17.5 KEY STRATEGIES .............................................. 174
11.18 PETER LAZIC GMBH .................................................... 175
11.18.1 COMPANY OVERVIEW ....................................... 175
11.18.2 FINANCIAL OVERVIEW ...................................... 176
11.18.3 PRODUCT OFFERED .......................................... 176
11.18.4 KEY DEVELOPMENTS ........................................ 176
11.18.5 KEY STRATEGIES .............................................. 176
11.19 ALCON INC ...................................................................... 177
11.19.1 COMPANY OVERVIEW ....................................... 177
11.19.2 FINANCIAL OVERVIEW ...................................... 178
11.19.3 PRODUCT OFFERED .......................................... 178
11.19.4 KEY DEVELOPMENTS ........................................ 179
11.19.5 KEY STRATEGIES .............................................. 179
11.20 SYNOVIS MICRO COMPANIES ALLIANCE, INC .. 180
11.20.1 COMPANY OVERVIEW ....................................... 180
11.20.2 FINANCIAL OVERVIEW ...................................... 181
11.20.3 PRODUCT OFFERED .......................................... 181
11.20.4 KEY DEVELOPMENTS ........................................ 181
11.20.5 KEY STRATEGIES .............................................. 181
12 DATA CITATIONS ........................... 182